CA Patent

CA2352194A1 — Azepinoindole derivatives, the production and use thereof

Assigned to Abbott GmbH and Co KG · Expires 2001-04-05 · 25y expired

What this patent protects

The invention relates to compounds of formula (I) as well as to the tautomer ic forms thereof, possible enantiomeric and diastereomeric forms and the prodru gs thereof, the production and use thereof, whereby the values have the meaning as given in the description.

USPTO Abstract

The invention relates to compounds of formula (I) as well as to the tautomer ic forms thereof, possible enantiomeric and diastereomeric forms and the prodru gs thereof, the production and use thereof, whereby the values have the meaning as given in the description.

Drugs covered by this patent

Patent Metadata

Patent number
CA2352194A1
Jurisdiction
CA
Classification
—
Expires
2001-04-05
Drug substance claim
No
Drug product claim
No
Assignee
Abbott GmbH and Co KG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.